Showing results (111-120 of 431) with videos related to
Sort By:
Pageof 44
Cancer Science|November 13, 2003
Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patientsHirokazu Watanabe, Seiichiro Yamamoto, Hideo Kunitoh, et al.Cancer Science|September 20, 2018
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumabShiro Kimbara, Yutaka Fujiwara, Shintaro Iwama, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2006
Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patientsIkuo Sekine, Minako Sumi, Yoshinori Ito, et al.Japanese Journal of Clinical Oncology|April 12, 2007
Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or olderToshio Shimizu, Ikuo Sekine, Minako Sumi, et al.Japanese Journal of Clinical Oncology|November 8, 2014
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†Hiroko Tsukada, Akira Yokoyama, Koichi Goto, et al.Respiratory Investigation|July 4, 2024
The remarkable antitumor efficacy of corticosteroid treatment in patients with refractory thymomasTomohiro Tanaka, Yasushi Goto, Ken Masuda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Severe interstitial lung disease associated with amrubicin treatmentKiyotaka Yoh, Hirotsugu Kenmotsu, Yoko Yamaguchi, et al.Lung Cancer (Amsterdam, Netherlands)|July 15, 2015
Cytotoxic chemotherapy may overcome the development of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapyShintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, et al.Clinical Lung Cancer|July 19, 2016
Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line ChemotherapyKoichi Saruwatari, Shigeki Umemura, Shogo Nomura, et al.Japanese Journal of Clinical Oncology|April 25, 2007
Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancerIkuo Sekine, Minako Sumi, Yoshinori Ito, et al.Pageof 44